These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8676565

  • 1. [Analysis of factors which affect the measurement of factor VIII inhibitor by Bethesda method].
    Takahashi Y, Arai M, Fukutake K.
    Rinsho Byori; 1996 May; 44(5):449-55. PubMed ID: 8676565
    [Abstract] [Full Text] [Related]

  • 2. Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience.
    Peerschke EI, Castellone DD, Ledford-Kraemer M, Van Cott EM, Meijer P, NASCOLA Proficiency Testing Committee.
    Am J Clin Pathol; 2009 Apr; 131(4):552-8. PubMed ID: 19289591
    [Abstract] [Full Text] [Related]

  • 3. The between-laboratory variation of factor VIII inhibitor testing: the experience of the external quality assessment program of the ECAT foundation.
    Meijer P, Verbruggen B.
    Semin Thromb Hemost; 2009 Nov; 35(8):786-93. PubMed ID: 20169515
    [Abstract] [Full Text] [Related]

  • 4. Development of a new modified Bethesda method for coagulation inhibitors: the Osaka modified Bethesda method.
    Torita S, Suehisa E, Kawasaki T, Toku M, Takeo E, Tomiyama Y, Nishida S, Hidaka Y.
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):185-9. PubMed ID: 21245748
    [Abstract] [Full Text] [Related]

  • 5. Clinical patterns of hemophilic patients who develop inhibitors.
    McMillan CW.
    Prog Clin Biol Res; 1984 Apr; 150():31-44. PubMed ID: 6431436
    [Abstract] [Full Text] [Related]

  • 6. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.
    Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E.
    Thromb Haemost; 1995 Feb; 73(2):247-51. PubMed ID: 7792738
    [Abstract] [Full Text] [Related]

  • 7. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L, Pitlik E.
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
    Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, Just S, Sioufi J, Street A, Marsden K, RCPA QAP in Haematology Haemostasis Committee.
    Thromb Haemost; 2006 Jul; 96(1):73-8. PubMed ID: 16807654
    [Abstract] [Full Text] [Related]

  • 17. [Transient inhibitors developed in two cases of hemophilia A].
    Fujiwara F, Kanoh G, Ogawa H, Takaya K, Hibi S, Shima M, Yoshioka A, Imashuku S.
    Rinsho Ketsueki; 1997 Dec; 38(12):1263-8. PubMed ID: 9455145
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
    Arai M.
    Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324
    [Abstract] [Full Text] [Related]

  • 20. [Characterization of the factor VIII inhibitor in a patient with chronic renal failure].
    Uemura Y, Niiya K, Takeuchi T, Miyoshi I.
    Rinsho Ketsueki; 1991 Jan; 32(1):39-42. PubMed ID: 1708430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.